Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalcetrapib in coronary artery disease assessed by IVUS, angiography, and carotid ultrasound
2009-017725-19Phase 3Terminated
- Sponsor
- Roche
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronary arteriosclerosis and atherosclerotic disease comparing Dalcetrapib with Placebo (2 arms). Primary endpoints: Co-primary endpoint 1, Co-primary endpoint 2 and 1 more. Started Apr 2010; status: terminated.
02
Drugs
dalcetrapib
03
Conditions
coronary arteriosclerosisatherosclerotic disease
Beyond the preview
Go deeper on 2009-017725-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017725-19.